Sajad A Wani Selected Research

enzalutamide

12/2023	Epigenetic disruption of the RARγ complex impairs its function to bookmark AR enhancer interactions required for enzalutamide sensitivity in prostate cancer.
11/2023	The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sajad A Wani Research Topics

Disease

5	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 11/2020
4	Neoplasms (Cancer) 11/2023 - 11/2020
1	Prostatic Intraepithelial Neoplasia 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Flatulence 12/2015
1	Cysts 01/2015
1	Echinococcosis (Hydatid Cysts) 01/2015
1	Pneumothorax 04/2014

Drug/Important Bio-Agent (IBA)

2	enzalutamideIBA 12/2023 - 11/2023
2	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 01/2022
2	AndrogensIBA 11/2023 - 12/2021
2	Co-Repressor ProteinsIBA 12/2021 - 11/2020
1	Estrogen Receptor betaIBA 11/2023
1	LigandsIBA 11/2023
1	hydroxide ionIBA 01/2023
1	Cholecalciferol (Vitamin D3)FDA Link 01/2023
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2023
1	ChromatinIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022
1	Estrogen Receptor alphaIBA 01/2022
1	Hormones (Hormone)IBA 11/2020
1	Coenzyme A (CoA)IBA 11/2020
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	Diatrizoate Meglumine (Gastrograffin)FDA LinkGeneric 12/2015
1	Albendazole (Albenza)FDA Link 01/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2015
1	Drug Therapy (Chemotherapy) 01/2022
1	Length of Stay 12/2015
1	Chest Tubes (Chest Tube) 04/2014